Selskabets formål er fabrikation og handel samt hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 665.1 mio. | 4.9 mio. | 685.2 mio. | 160.7 mio. | 265 | |
CVR: 33487819
Secondary names: JACOB HOLM VARDE A/S, DANAKLON INTERNATIONAL A/S, DANAKLON A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
KPMG P/S resigned as auditor
Compared to 3 companies in Fremstilling af kemofibre
Comparison is based on industry median values
The financial health of Indorama Ventures Hygiene Denmark A/S has shown signs of recovery in 2024, with revenue increasing to 665,104,000 DKK and a return to profitability with a profit of 4,897,000 DKK. However, the company faced significant challenges in the previous years, experiencing declining revenues and losses, particularly in 2023, where it reported a profit loss of 29,076,000 DKK. Equity has decreased from 273,368,000 DKK in 2020 to 160,731,000 DKK in 2024, raising concerns about its financial stability. Despite these challenges, the company remains a notable player in the chemical fiber manufacturing industry, indicating potential for recovery if the upward trend in revenue and profitability continues.
AI-generated summary
Companies in the same industry and area
companydata.dk